Real-time enrollment status for this epidermolysis bullosa simplex clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 12:07 PM UTC
| NCT Number | NCT06073132 |
| Recruiting Status | Recruiting |
| Condition | Epidermolysis Bullosa Simplex |
| Phase | Clinical Trial |
| Target Enrollment | 80 participants |
| Active Locations | 9 sites in the US |
| Sponsor | TWi Biotechnology, Inc. |
| Last Updated on CT.gov | November 19, 2025 (Nov 19, 2025) |
As of March 2, 2026: Clinical trial NCT06073132 is currently recruiting participants. This clinical trial study for epidermolysis bullosa simplex is actively seeking new participants at 9 locations across the United States. The study is sponsored by TWi Biotechnology, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06073132 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06073132 was last updated Nov 19, 2025 (November 19, 2025). HelloStudys verifies this status automatically.